Late endovascular revascularization in acute ischemic stroke based on clinical-diffusion mismatch

American Journal of Neuroradiology

Volumn 30, Issue 5, 2009, Pages 1024-1027

  Janjua, N ^a,b   El Gengaihy, A ^c   Pile Spellman, J ^d   Qureshi, A I ^e  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL DIFFUSION MISMATCH; CLINICAL EVALUATION; CONTROLLED STUDY; DETERIORATION; DIAGNOSTIC PROCEDURE; DIFFUSION WEIGHTED IMAGING; EARLY INTERVENTION; FEMALE; FOLLOW UP; HUMAN; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; STENT; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CHILD; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65949093738     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1474     Document Type: Article

References (22)

1. Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587
2. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study - a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011
3. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-1438 Epub 2005 Jun 16 (Pubitemid 40967507)
4. Gobin YP, Starkman S, Duckwiler GR, et al. Merci 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004;35:2848-2854 Epub 2004 Oct 28 (Pubitemid 39565182)
5. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-1212 Epub 2008 Feb 28
6. Clark WM, Albers GW, Madden KP, et al. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study - thromblytic therapy in acute ischemic stroke study investigators. Stroke 2000;31:811-816
7. Davis DP, Robertson T, Imbesi SG. Diffusion-weighted magnetic resonance imaging versus computed tomography in the diagnosis of acute ischemic stroke. J Emerg Med 2006;31:269-277 (Pubitemid 44374259)
8. Lansberg MG, Albers GW, Beaulieu C, et al. Comparison of diffusion-weighted MRI and CT in acute stroke. Neurology 2000;54:1557-1561 (Pubitemid 30226796)
9. Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 2007;369:293-298 (Pubitemid 46136489)
10. Davalos A, Blanco M, Pedraza S, et al. The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology 2004;62:2187-2192 (Pubitemid 38787773)
11. Prosser J, Butcher K, Allport L, et al. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 2005;36:1700-1704 (Pubitemid 41098765)
12. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy: ASPECTS Study Group Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-1674
13. Tei H, Uchiyama S, Usui T. Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction. J Neurol 2007;254:340-346 (Pubitemid 46399196)
14. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase - clinical findings through hospital discharge. Circulation 1987;76:142-154 (Pubitemid 17093202)
15. Chaturvedi S, Adams HP Jr, Woolson RF. Circadian variation in ischemic stroke subtypes. Stroke 1999;30:1792-1795 (Pubitemid 29411816)
16. Lago A, Geffner D, Tembl J, et al. Circadian variation in acute ischemic stroke: a hospital-based study. Stroke 1998;29:1873-1875 (Pubitemid 28399980)
17. Elliot WJ. Cyclic and circadian variations in cardiovascular events. Am J Hypertens 2001;14:291S-95S
18. Bang OY, Saver JL, Buck BH, et al. Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2008;79:625-629
19. Furlan AJ, Eyding D, Albers GW, et al. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227-1231 (Pubitemid 43731867)
20. Lee K, Han SW, Kim SH, et al. Low efficacy of intravenous TPA in acute cerebral infarction involving the large cerebral arteries. Paper presented at: International Stroke Conference; February 16-18, 2006; Kissimmee, Fla
21. Christou I, Burgin WS, Alexandrov AV, et al. Arterial status after intravenous TPA therapy for ischaemic stroke: a need for further interventions. Int Angiol 2001;20:208-213 (Pubitemid 33076872)
22. Linfante I, Llinas RH, Selim M, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002;33:2066-2071